))
Evaluating the Safety of COVID-19 Vaccines
Manage episode 345546631 series 3409958
Content provided by UnitedHealth Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UnitedHealth Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As the FDA went about the critical work of evaluating the safety of COVID-19 vaccines, the agency tapped Optum Scientific Consulting, with a 25-year history of evaluating drugs and vaccines. In this episode, Optum's Chief Scientific Officer John Seeger explains:
- Optum Scientific Consulting's history of evaluating drugs and vaccines.
- The group's partnership with the FDA to evaluate COVID-19 vaccines for kids ages 5 to 11.
- The broader impact and promise of data on drug and vaccine safety.
40 episodes
Share
